News

FDA may ask Novavax to conduct additional trials of its Covid-19 vaccine to receive full approval
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
US FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports
Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...
Novavax Falls on Report That FDA Wants New Covid Vaccine Trial
Novavax Inc. shares fell after the Wall Street Journal reported that US regulators asked the company to conduct another ...
FDA still negotiating whether to grant full approval to Novavax COVID-19 vaccine
The U.S. Food and Drug Administration (FDA) is still negotiating whether to grant full approval to Novavax's COVID-19 vaccine ...
FDA asks Novavax to complete new clinical trial for delayed COVID-19 shot, WSJ reports
(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...
As FDA delays Novavax' COVID vaccine approval, patients fight back
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...
Novavax says its COVID-19 shot is on track for full FDA approval after delay
Novavax says its closely watched COVID-19 vaccine is on track for full U.S. approval after additional discussions with the ...
Novavax told by FDA to conduct additional study for COVID vaccine - report
Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.
Novavax COVID vaccine moves closer to full FDA approval
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...
Novavax asked by FDA to complete additional COVID trial, WSJ says
EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...
Novavax down 10% after WSJ report on FDA request for additional vaccine trial
EDT Novavax (NVAX) down 10% after WSJ report on FDA request for additional vaccine trialStay Ahead of the Market: Discover outperforming ...
Novavax Slips After WSJ Report on FDA Request for Another Vaccine Study
Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...